Eissing, Thomas

Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model

Kuepfer, L., Niederalt, C., Wendl, T., Schlender, J., Willmann, S., Lippert, J., Block, M., Eissing, T., & Teutonico, D. (2016) · CPT: Pharmacometrics & Systems Pharmacology

Antibiotics Pharmacokinetics and EfficacyPharmaceutical studies and practices

Cited by 425

A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks

Eissing, T. (2011) · Frontiers in Physiology

Mathematical Biology Tumor GrowthComputational Drug Discovery Methods

Cited by 204

PBPK Models for CYP3A4 and P‐gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin

Hanke, N., Frechen, S., Moj, D., Britz, H., Eissing, T., Wendl, T., & Lehr, T. (2018) · CPT: Pharmacometrics & Systems Pharmacology

Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Cited by 169

A Quantitative Systems Pharmacology Kidney Model of Diabetes Associated Renal Hyperfiltration and the Effects of SGLT Inhibitors

Balazki, P., Schaller, S., Eissing, T., & Lehr, T. (2018) · CPT: Pharmacometrics & Systems Pharmacology

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 19